Shamburg News · 8-K filed Oct 28, 2026, 4:02 PM EDT
Gossamer Bio Stockholders Approve Share Issuance Under August 2026 Securities Purchase Agreement
GOSS · Gossamer Bio, Inc.
- Shareholder vote
- Financing
- Materiality: medium
Gossamer Bio, Inc. held a special meeting of stockholders on October 27, 2026. Stockholders approved, under Nasdaq Listing Rules 5635(c) and 5635(d), the potential issuance of common stock under the Securities Purchase Agreement dated August 20, 2026, including shares issuable on exercise of pre-funded warrants and FDA approval warrants and on conversion of Series A preferred stock. The proposal received 2,808,000 votes for, 37,814 against, and 29,441 abstentions. The adjournment proposal was not called because the share issuance proposal was approved.
Source: SEC EDGAR, Form 8-K, Item 5.07, accession 0001728117-26-000109.
Written from the filing by Shamburg Markets. Figures are as reported by the company.